Wuxi Biortus Biosciences

Compound screening against a drug target is a vital step in early-stage drug discovery, and Biortus has an extensive collection of testing equipment enabling development of many kinds of biochemical, biophysical and cell-based assays, with key assays including SPR, kinase, ADP-Glo, TR-FRET, FP and calcium flux assays.